• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVF-XL
Device Problems Perivalvular Leak (1457); Malposition of Device (2616)
Patient Problem Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 11/27/2023
Event Type  Injury  
Manufacturer Narrative
H3 other text : the valve has been received and investigation is ongoing.
 
Event Description
On (b)(6) 2023, a perceval plus pvf-xl was attempted to be implanted in a patient.After implantation, a perivalvular leak was noted.As such, the valve was replaced with the valve with other model and size during the same day.No further information is available at this time.
 
Manufacturer Narrative
The manufacturing and material records for the perceval plus heart valve and stent, model # pvf-xl, s/n # (b)(6), as they pertain to the reported event, were retrieved and reviewed by the manufacture¿s quality engineering.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model # pvf-xl) perceval plus heart valve at the time of manufacture and release.Device has been returned to the manufacturer.After decontamination, the valve was visually inspected without observing any macroscopic anomalies and/or pre-existing defects according to the specifications.The replication of collapsing phases was performed using the returned valve pvf-s and a demo accessory kit, in order to attempt to reproduce the reported event.No problems were encountered in the collapsing phase, and the replication has been completed without problem.No problems were encountered during the deployment in silicon aortic roots #27, and the ballooning phase, and the sealing at the annulus level is guaranteed as visible in attached pictures thus, the valve remained fixed within the annulus.Then, inserting some water in the aortic roots from the outflow side, no paravalvular leaks were observed during the simulation.Considering the static conditions of the test, the water level remained stable under the leaflets free edge.Based on the performed analyses, it is possible to exclude the relationship between the reported issue and the returned device quality.Furthermore, from the document review performed, no manufacturing defects were noted.Based on the medical judgment received, the cause of the reported event was related to mispositioning of the valve.Furthermore, it is reported that the valve was attempted to be re-collapsed.As explained in the perceval instructions for use, "a removed perceval prosthesis must not be re-implanted, because its integrity is no longer ensured." as such, the decision to re-collapse the valve was made off-label.
 
Event Description
On (b)(6) 2023, a perceval plus pvf-xl was attempted to be implanted in a patient.After implantation, a perivalvular leak was noted.As such, the valve was replaced with the valve with other model and size during the same day.Based on the medical judgment received, the issue as not leak.The valve was originally mispositioned.As such, it was explanted and re-collapsed but prior to second implantation, a black wire was noted that did seem detached and surgeon did not know if this was normal, so the decision was made to implant an inspiris size 25 instead.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
laura mannino
5005 north fraser way
burnaby, bc 
MDR Report Key18414798
MDR Text Key331581651
Report Number3004478276-2023-00221
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000825
UDI-Public(01)00896208000825(240)PVF-XL(17)240723
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011/S013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/16/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPVF-XL
Device Catalogue NumberPVF-XL
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/14/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received01/18/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/23/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
Patient SexMale
-
-